(Q37930443)

25 August 2017

1 reference

title

Natural products and Pharma 2011: strategic changes spur new opportunities (English)

1 reference

25 August 2017

1 reference

Guy T Carter

1

1 reference

25 August 2017

publication date

12 September 2011

1 reference

25 August 2017

published in

Natural Product Reports

1 reference

25 August 2017

volume

28

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1783-1789

1 reference

Can the pharmaceutical industry reduce attrition rates?

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Designed multiple ligands. An emerging drug discovery paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Scaffolds for blocking protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

The exploration of macrocycles for drug discovery--an underexploited structural class

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Pre-fractionated microbial samples--the second generation natural products library at Wyeth

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Function-oriented synthesis, step economy, and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Macrocyclic ketone analogues of halichondrin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Natural products version 2.0: connecting genes to molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

A genomics-guided approach for discovering and expressing cryptic metabolic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Polyketide synthase chemistry does not direct biosynthetic divergence between 9- and 10-membered enediynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Genome mining for ribosomally synthesized natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

The discovery of salinosporamide K from the marine bacterium "Salinispora pacifica" by genome mining gives insight into pathway evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

From natural products discovery to commercialization: a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Improvement of secondary metabolite production in Streptomyces by manipulating pathway regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Engineered Streptomyces platensis strains that overproduce antibiotics platensimycin and platencin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00033K

Halichondrins - antitumor polyether macrolides from a marine sponge

21 January 2018

1 reference

20 August 2023

https://opencitations.net/index/coci/api/v1/citations/10.1351/PAC198658050701

Identifiers

DOI

10.1039/C1NP00033K

1 reference

25 August 2017

1 reference